{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:50:54Z","timestamp":1785552654144,"version":"3.56.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T00:00:00Z","timestamp":1657324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 EY008976"],"award-info":[{"award-number":["R01 EY008976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Autoimmune Center of Excellence","award":["AR088974"],"award-info":[{"award-number":["AR088974"]}]},{"name":"NEI Core","award":["EY007003"],"award-info":[{"award-number":["EY007003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Teprotumumab, an IGF-I receptor (IGF-IR) inhibitor, is effective in thyroid-associated ophthalmopathy (TAO). The drug can modulate induction by TSH of IL-6 and IL-8 in CD34+\u2005fibrocytes and their putative derivatives, CD34+\u2005orbital fibroblasts (CD34+\u2005OF). Fibrocytes express multiple thyroid autoantigens and cytokines implicated in TAO, which are downregulated by Slit2. Inflammation and disordered hyaluronan (HA) accumulation occur in TAO. Whether teprotumumab alters these processes directly in fibrocytes\/CD34+\u2005OF remains uncertain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Determine teprotumumab effects on expression\/synthesis of several TAO-relevant molecules in fibrocytes and GD-OF.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design\/Setting\/Participants<\/jats:title>\n                  <jats:p>Patients with TAO and healthy donors were recruited from an academic endocrine and oculoplastic practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Real-time PCR, specific immunoassays.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Teprotumumab attenuates basal and TSH-inducible autoimmune regulator protein, thyroglobulin, sodium iodide symporter, thyroperoxidase, IL-10, and B-cell activating factor levels in fibrocytes. It downregulates IL-23p19 expression\/induction while enhancing IL-12p35, intracellular and secreted IL-1 receptor antagonists, and Slit2. These effects are mirrored by linsitinib. HA production is marginally enhanced by teprotumumab, the consequence of enhanced HAS2 expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Teprotumumab affects specific gene expression in fibrocytes and GD-OF in a target-specific, nonmonolithic manner, whereas IGF-IR control of these cells appears complex. The current results suggest that the drug may act on cytokine expression and HA production systemically and locally, within the TAO orbit. These findings extend our insights into the mechanisms through which IGF-IR inhibition might elicit clinical responses in TAO, including a potential role of Slit2 in attenuating inflammation and tissue remodeling.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac415","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T20:37:19Z","timestamp":1657399039000},"page":"e4037-e4047","source":"Crossref","is-referenced-by-count":12,"title":["Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy"],"prefix":"10.1210","volume":"107","author":[{"given":"Roshini","family":"Fernando","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center , Ann Arbor, MI 48105 , USA"},{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6279-9685","authenticated-orcid":false,"given":"Terry J","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Kellogg Eye Center , Ann Arbor, MI 48105 , USA"},{"name":"Division of Metabolism, Endocrinology and Diabetes, Department of Internal Medicine, University of Michigan Medical School , Ann Arbor, MI 48105 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,7,9]]},"reference":[{"key":"2022092808414144300_CIT0001","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archopht.120.3.380","article-title":"Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy","volume":"120","author":"Kazim","year":"2002","journal-title":"Arch Ophthalmol."},{"key":"2022092808414144300_CIT0002","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves\u2019 disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med."},{"key":"2022092808414144300_CIT0003","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0140-6736(93)91475-2","article-title":"Expression of thyrotropin-receptor mRNA in healthy and Graves\u2019 disease retro-orbital tissue","volume":"342","author":"Feliciello","year":"1993","journal-title":"Lancet."},{"key":"2022092808414144300_CIT0004","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/thy.1993.3.297","article-title":"Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves\u2019 ophthalmopathy and pretibial dermopathy","volume":"3","author":"Heufelder","year":"1993","journal-title":"Thyroid."},{"key":"2022092808414144300_CIT0005","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1210\/jc.2004-0716","article-title":"Immunoglobulins from patients with Graves\u2019 disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor","volume":"89","author":"Smith","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0006","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2009-1614","article-title":"Increased generation of fibrocytes in thyroid-associated ophthalmopathy","volume":"95","author":"Douglas","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/thy.2009.0278","article-title":"A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves\u2019 orbital preadipocyte fibroblasts","volume":"20","author":"Kumar","year":"2010","journal-title":"Thyroid."},{"key":"2022092808414144300_CIT0008","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40618-015-0254-2","article-title":"Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy","volume":"38","author":"Ponto","year":"2015","journal-title":"J Endocrinol Invest."},{"key":"2022092808414144300_CIT0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3341\/kjo.2015.29.4.213","article-title":"Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves\u2019 orbitopathy","volume":"29","author":"Woo","year":"2015","journal-title":"Korean J Ophthalmol."},{"key":"2022092808414144300_CIT0010","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol."},{"key":"2022092808414144300_CIT0011","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4049\/jimmunol.168.2.942","article-title":"Igs from patients with Graves\u2019 disease induce the expression of T cell chemoattractants in their fibroblasts","volume":"168","author":"Pritchard","year":"2002","journal-title":"J Immunol."},{"key":"2022092808414144300_CIT0012","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves\u2019 disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol."},{"key":"2022092808414144300_CIT0013","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1089\/thy.2017.0281","article-title":"Response to Krieger et al. re: \u201cTSHR\/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves\u2019 Ophthalmopathy Pathogenesis\u201d (Thyroid 2017;27:746-747)","volume":"27","author":"Smith","year":"2017","journal-title":"Thyroid."},{"key":"2022092808414144300_CIT0014","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med."},{"key":"2022092808414144300_CIT0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med."},{"key":"2022092808414144300_CIT0016","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s40265-020-01287-y","article-title":"Teprotumumab: first approval","volume":"80","author":"Markham","year":"2020","journal-title":"Drugs."},{"key":"2022092808414144300_CIT0017","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114244118","article-title":"Therapeutic IGF-I receptor inhibition alters fibrocyte immune phenotype in thyroid-associated ophthalmopathy","author":"Fernando","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022092808414144300_CIT0018","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrendo.2014.226","article-title":"TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy","volume":"11","author":"Smith","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"2022092808414144300_CIT0019","first-page":"2620","article-title":"Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts","volume":"80","author":"Smith","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/jcem.87.1.8164","article-title":"Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0021","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2018-01493","article-title":"Potential roles of CD34+ fibrocytes masquerading as orbital fibroblasts in thyroid-associated ophthalmopathy","volume":"104","author":"Smith","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0022","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03403533","article-title":"Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair","volume":"1","author":"Bucala","year":"1994","journal-title":"Mol Med."},{"key":"2022092808414144300_CIT0023","doi-asserted-by":"crossref","first-page":"7427","DOI":"10.1073\/pnas.1202064109","article-title":"Human fibrocytes coexpress thyroglobulin and thyrotropin receptor","volume":"109","author":"Fernando","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022092808414144300_CIT0024","doi-asserted-by":"crossref","first-page":"E1236","DOI":"10.1210\/jc.2013-4271","article-title":"Expression of thyrotropin receptor, thyroglobulin, sodium-iodide symporter, and thyroperoxidase by fibrocytes depends on AIRE","volume":"99","author":"Fernando","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0025","article-title":"Slit2 regulates hyaluronan & cytokine synthesis in fibrocytes: Potential relevance to thyroid associated ophthalmopathy","author":"Fernando","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0026","first-page":"4079","article-title":"Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"84","author":"Kaback","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0027","doi-asserted-by":"crossref","first-page":"25117","DOI":"10.1074\/jbc.273.39.25117","article-title":"Molecular cloning and characterization of the human and mouse UDP-glucose dehydrogenase genes","volume":"273","author":"Spicer","year":"1998","journal-title":"J Biol Chem."},{"key":"2022092808414144300_CIT0028","doi-asserted-by":"crossref","first-page":"24487","DOI":"10.1074\/jbc.M111.241166","article-title":"Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease","volume":"286","author":"Tsui","year":"2011","journal-title":"J Biol Chem."},{"key":"2022092808414144300_CIT0029","doi-asserted-by":"crossref","first-page":"E1635","DOI":"10.1210\/jc.2014-1580","article-title":"Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes","volume":"99","author":"Chen","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0030","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.4049\/jimmunol.1800259","article-title":"Slit2 modulates the inflammatory phenotype of orbit-infiltrating fibrocytes in Graves\u2019 disease","volume":"200","author":"Fernando","year":"2018","journal-title":"J Immunol."},{"key":"2022092808414144300_CIT0031","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4049\/jimmunol.1900434","article-title":"Slit2 may underlie divergent induction by thyrotropin of IL-23 and IL-12 in human fibrocytes","volume":"204","author":"Fernando","year":"2020","journal-title":"J Immunol."},{"key":"2022092808414144300_CIT0032","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1210\/clinem\/dgaa684","article-title":"Slit2 regulates hyaluronan & cytokine synthesis in fibrocytes: potential relevance to thyroid-associated ophthalmopathy","volume":"106","author":"Fernando","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0033","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3109\/9780203908983-23","article-title":"Role of orbital fat in thyroid-associated ophthalmopathy. Graves\u2019 Associated Orbital Disease.","volume-title":"Thyroid Eye Disease: Diagnosis and Treatment","author":"Smith","year":"2002"},{"key":"2022092808414144300_CIT0034","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jcem-69-5-1019","article-title":"Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: evidence for differences between retroocular and dermal fibroblasts","volume":"69","author":"Smith","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0035","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/eji.200939305","article-title":"IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo","volume":"39","author":"Gyulveszi","year":"2009","journal-title":"Eur J Immunol."},{"key":"2022092808414144300_CIT0036","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1749-6632.1991.tb17266.x","article-title":"Role of a new cytokine, interleukin-10, in the cross-regulation of T helper cells","volume":"628","author":"Mosmann","year":"1991","journal-title":"Ann N Y Acad Sci."},{"key":"2022092808414144300_CIT0037","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/dxh207","article-title":"CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production","volume":"17","author":"Barthlott","year":"2005","journal-title":"Int Immunol."},{"key":"2022092808414144300_CIT0038","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nri844","article-title":"BAFF: a fundamental survival factor for B cells","volume":"2","author":"Mackay","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"2022092808414144300_CIT0039","first-page":"1005","article-title":"BAFF: a novel therapeutic target for autoimmunity","volume":"3","author":"Kalled","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"2022092808414144300_CIT0040","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/edrv-10-3-366","article-title":"Connective tissue, glycosaminoglycans, and diseases of the thyroid","volume":"10","author":"Smith","year":"1989","journal-title":"Endocr Rev."},{"key":"2022092808414144300_CIT0041","doi-asserted-by":"crossref","first-page":"18291","DOI":"10.1073\/pnas.1417426112","article-title":"Fibroblasts secrete Slit2 to inhibit fibrocyte differentiation and fibrosis","volume":"111","author":"Pilling","year":"2014","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022092808414144300_CIT0042","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1210\/en.2015-1464","article-title":"Disrupted TSH receptor expression in female mouse lung fibroblasts alters subcellular IGF-1 receptor distribution","volume":"156","author":"Atkins","year":"2015","journal-title":"Endocrinology."},{"key":"2022092808414144300_CIT0043","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1210\/jc.2014-3566","article-title":"Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves\u2019 disease immunoglobins","volume":"100","author":"Krieger","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0044","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgac045","article-title":"It takes two to tango: IGF-I and TSH receptors in thyroid eye disease","author":"Girnita","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2022092808414144300_CIT0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12902-021-00752-3","article-title":"Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves\u2019 disease","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Endocr. Disord"},{"key":"2022092808414144300_CIT0046","doi-asserted-by":"crossref","first-page":"C382","DOI":"10.1152\/ajpcell.1995.268.2.C382","article-title":"Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts","volume":"268","author":"Smith","year":"1995","journal-title":"Am J Physiol."},{"key":"2022092808414144300_CIT0047","doi-asserted-by":"crossref","first-page":"29615","DOI":"10.1074\/jbc.273.45.29615","article-title":"Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy","volume":"273","author":"Cao","year":"1998","journal-title":"J Biol Chem."},{"key":"2022092808414144300_CIT0048","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1074\/jbc.273.4.1923","article-title":"Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family","volume":"273","author":"Spicer","year":"1998","journal-title":"J Biol Chem."},{"key":"2022092808414144300_CIT0049","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1210\/jc.2018-01626","article-title":"Insights into local orbital immunity: evidence for the involvement of the Th17 cell pathway in thyroid-associated ophthalmopathy","volume":"104","author":"Fang","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0050","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.intimp.2020.107300","article-title":"Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy","volume":"91","author":"Pan","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"2022092808414144300_CIT0051","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1210\/jc.2013-1245","article-title":"Divergent expression of IL-1 receptor antagonists in CD34(+) fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation","volume":"98","author":"Li","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0052","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1210\/jc.2014-1257","article-title":"PI3K\/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0053","doi-asserted-by":"crossref","first-page":"E625","DOI":"10.1210\/jc.2013-3977","article-title":"Regulation of IL-1 receptor antagonist by TSH in fibrocytes and orbital fibroblasts","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0054","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1210\/clinem\/dgab035","article-title":"Genetic profiling of orbital fibroblasts from patients with graves\u2019 orbitopathy","volume":"106","author":"Dottore","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"2022092808414144300_CIT0055","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.4049\/jimmunol.173.5.3564","article-title":"Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves\u2019 disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor","volume":"173","author":"Pritchard","year":"2004","journal-title":"J Immunol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac415\/45328814\/dgac415.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/10\/e4037\/46112704\/dgac415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/10\/e4037\/46112704\/dgac415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T08:47:26Z","timestamp":1664354846000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/10\/e4037\/6638970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,9]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,7,9]]},"published-print":{"date-parts":[[2022,9,28]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac415","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,1]]},"published":{"date-parts":[[2022,7,9]]}}}